Article Details

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion ...

Retrieved on: 2025-05-22 15:15:07

Tags for this article:

Click the tags to see associated articles and topics

Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion .... View article details on hiswai:

Summary

The article discusses the impact of COVID-19, increasing demand for diagnostic testing, and the performance of medical product stocks within Zacks Investment Research's analysis. It relates to investment insights and market movements in sectors influenced by COVID, including devices like insulin management systems.

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo